APR 18, 2016 12:17 PM PDT

Simple Sugar to Detect Human Brain Tumors in MRIs

WRITTEN BY: Xuan Pham
Safer way to administer brain MRIs Brain imaging via MRIs may soon be enhanced with simple sugar instead of conventional metal complexes. A pilot study found that a common form of sugar, known as dextrose, is a viable and safer alternative for tumor imaging.
 
Magnetic resonance imaging (MRI) is a technique that uses magnetic field and radio waves to build a picture of organs and structures inside the body. Although MRIs can be performed alone, clinicians often rely on use of agents that enhance the contrast of the image to better detect the details. An agent commonly used for this purpose is gadolinium, which is a naturally occurring metal. Gadolinium MRI contrast agents are useful, but it has known toxicities, including side effects in kidney patients. Furthermore, gadolinium can build-up in the body as deposits in the brain, especially for patients who require repeat MRIs.
 
To overcome this challenge, the international research team exploited tumor’s biology, mainly that tumors consume more sugar than normal tissues. Thus, they used dextrose, also known as D-glucose, as an MRI contrast agent. In a pilot study involving four normal volunteers and three patients with brain tumors, the team found comparable results between traditional gadolinium-enhanced MRIs and glucose-enhanced MRIs.
 
"This is the first non-metallic, biodegradable, natural MRI contrast agent tested in humans," sad Guoying Liu, Director of the National Institute of Biomedical Imaging and Bioengineering Program in Magnetic Resonance Imaging and Spectroscopy. "Developing these natural contrast agents is critical for patients who require repeated imaging; additionally it will increase patient acceptance and comfort with imaging procedures."
 
Using glucose could have bigger safety and efficacy potential, as noted by Peter van Zijl, the study’s senior author. According to him, recent studies have found gadolinium deposits in bone and the brain, indicating more residuals that could cause harm. “These recent published findings are showing that gadolinium deposition in tissue could be more common than previously thought, so the development of a natural contrast agent alternative is certainly a high priority for the imaging community and, of course, patients,” said van Zijl.
 
Furthermore, glucose may penetrate the blood-brain barrier more efficiently than gadolinium due to its smaller size. This means that glucose-enhanced MRIs should detect close to 100 percent of high-grade tumors, in contrast to the 70 to 80 percent detected by gadolinium MRIs.
 
"It is a significant step to be able to obtain clear MRI images of the brain using a biocompatible substance that is metabolized naturally by the body relatively quickly," said Zijl. "The dose of D-glucose is similar to that used for diabetes testing and is much cheaper than the metallic agents." In the next phase, the team will test the technique in a larger patient sample, and they the forthcoming promising results will expedite FDA approval for mass use.
 

Additional sources: NIBIB
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 12, 2020
Cancer
Treating cancer with the botanical andrographis
SEP 12, 2020
Treating cancer with the botanical andrographis
A study from City of Hope published in the journal Carcinogenesis reports that the use of the natural botanical And ...
OCT 04, 2020
Cancer
Mutations form in specific genomic patterns based on external and internal factors
OCT 04, 2020
Mutations form in specific genomic patterns based on external and internal factors
New research published in Nature Genetics provides insight on the formation of mutations in the genome. Researchers from ...
OCT 07, 2020
Cancer
Beyond the eye: improving melanoma detection
OCT 07, 2020
Beyond the eye: improving melanoma detection
Research from UC San Francisco reports that it is possible to use genomic methods to detect skin damage from the sun not ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 18, 2020
Cancer
Could Targeting the Proteasome be Effective Against Cancer?
NOV 18, 2020
Could Targeting the Proteasome be Effective Against Cancer?
One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical ...
Loading Comments...